⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
ENT Disorder Treatment Market to Reach US$58 Billion by 2034, Driven by Digital Diagnostics and Minimally Invasive Car
globenewswire.com
GSK
SNY
PFE
AZN
NVS
ABBV
JNJ
MRK
MDT
SN
BSX
TEVA
SUN
Bronstein, Gewirtz & Grossman, LLC Encourages AstraZeneca PLC (AZN) Investors to Inquire about Securities Investigation
accessnewswire.com
AZN
AZN Investor Alert: Levi & Korsinsky Investigates AstraZeneca PLC (AZN) for Potential Securities Fraud
accessnewswire.com
AZN
AZN Investor Alert: Levi & Korsinsky Investigates AstraZeneca PLC (AZN) for Potential Securities Fraud
accessnewswire.com
AZN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZN
accessnewswire.com
AZN
Oral Obesity Therapies Market to Reach $6.32 Billion by 2030 as Demand for GLP-1 Treatments Accelerates
globenewswire.com
MRK
PFE
AZN
LLY
VKTX
STRT
AZN Investor Alert: Levi & Korsinsky Investigates AstraZeneca PLC (AZN) For Potential Securities Fraud
accessnewswire.com
AZN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
globenewswire.com
AZN
Tuberculosis Clinical Trial Pipeline Shows Potential with Active Contributions from 28+ Key Companies | DelveInsight
globenewswire.com
FMS
BIIB
MDT
NVO
LLY
AZN
RDNT
LXRX
SNY
XRTX
RGEN
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving AstraZeneca (AZN)
globenewswire.com
AZN